Precision diagnosis of lupus nephritis: opportunities and role of biomarkers
Journal Title: Нирки - Year 2019, Vol 8, Issue 2
Abstract
The most common complication in patients with systemic lupus erythematosus is lupus nephritis (LN), a condition that can lead to end-stage kidney disease. In recent years, many serum and urine biomarkers, genetic studies have been proposed for the diagnosis of LN, but none of them entered into guidelines for clinical use. The majority of studies have been single-center with significant variability in cohorts, assays, and sample storage, leading to inconclusive results. It has become clear that no single biomarker is likely to be sufficient to diagnose LN, identify flares, and define the response to therapy and prognosis. A more likely scenario for future diagnostics is a panel of biomarkers for urine, serum, kidney tissue, and genetic biomarkers. The review summarizes the data on traditional and new serum, urinary and genetic biomarkers, discusses the feasibility of their use in clinical practice and the possibility of implementation for a more accurate diagnosis of LN. Each “panel” of biomarkers will provide a unique understanding of the various clinical issues of disease development and progression. Thus, the genetic panel can determine the likelihood of nephritis in a patient with systemic lupus erythematosus and which inflammatory pathways will be involved in the LN development. A urine biomarker panel can help distinguish between inflammation and fibrosis, eliminating the need for repeated biopsies. A serum biomarker panel can identify nephritogenic autoantibodies that increase the number of exacerbations, cause their severity and worsen the response to treatment. A more systematic and focused approach to the study of biomarkers will allow precision diagnosis to become a reality for patients with LN.
Authors and Affiliations
I. Yu. Golovach, Ye. D. Yehudina
Keywords
Related Articles
- EP ID EP570395
- DOI 10.22141/2307-1257.8.2.2019.166666
- Views 94
- Downloads 0
Precision diagnosis of lupus nephritis: opportunities and role of biomarkers
The most common complication in patients with systemic lupus erythematosus is lupus nephritis (LN), a condition that can lead to end-stage kidney disease. In recent years, many serum and urine biomarkers, genetic studies...
Diagnostic role of radionuclide methods in patients with pyelonephritis
Acute and chronic forms of pyelonephritis are the most common diseases of the urinary system in all age groups. The incidence rate of acute pyelonephritis in children is 19.1 per 1000, chronic pyelonephritis — 5–12.5 per...
Renal Artery Stenosis of the Transplanted Kidney
The article describes the results of observation of the patient with stenosis of the main artery of the transplanted kidney before and after balloon dilation of stenosis. The kidney was studied by Ultrasound, Doppler and...
Metabolic syndrome and the risk of chronic kidney disease
Metabolic syndrome (MS) is a combination of a disorder of carbohydrate metabolism, abdominal obesity, dyslipidemia and arterial hypertension. Studies show that there is a close relationship between MS and chronic kidney...
Drug treatment of phosphate-calcium metabolism disorders in patients with chronic kidney disease and mineral and bone disorder
Changes in phosphate-calcium metabolism commonly occurred in patients with chronic kidney disease and are a major pathogenetic factor in the development of secondary hyperparathyroidism and mineral and bone disorder in t...